Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis
about
Feedback inhibition of osteoclastogenesis during inflammation by IL-10, M-CSF receptor shedding, and induction of IRF8Modulation of osteoclastogenesis with macrophage M1- and M2-inducing stimuliToll-Like Receptor 4 Signaling Pathway Mediates Inhalant Organic Dust-Induced Bone LossMolecular mechanism of thiazolidinedione-mediated inhibitory effects on osteoclastogenesis.Infection of RANKL-primed RAW-D macrophages with Porphyromonas gingivalis promotes osteoclastogenesis in a TNF-α-independent manner.Secretion of a truncated osteopetrosis-associated transmembrane protein 1 (OSTM1) mutant inhibits osteoclastogenesis through down-regulation of the B lymphocyte-induced maturation protein 1 (BLIMP1)-nuclear factor of activated T cells c1 (NFATc1) axTLR2-dependent modulation of osteoclastogenesis by Porphyromonas gingivalis through differential induction of NFATc1 and NF-kappaB.Toll-like receptor 4 mediates the regenerative effects of bone grafts for calvarial bone repairMolecular mechanisms of the biphasic effects of interferon-γ on osteoclastogenesis.Rhinacanthin C Inhibits Osteoclast Differentiation and Bone Resorption: Roles of TRAF6/TAK1/MAPKs/NF-κB/NFATc1 SignalingOsteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial InvasionThe role of SH3BP2 in the pathophysiology of cherubism.Melatonin Receptor Agonists as the "Perioceutics" Agents for Periodontal Disease through Modulation of Porphyromonas gingivalis Virulence and Inflammatory ResponseNucleosides accelerate inflammatory osteolysis, acting as distinct innate immune activators.Augmented LPS responsiveness in type 1 diabetes-derived osteoclasts.Serum amyloid A inhibits RANKL-induced osteoclast formation.IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1).Regulators of G protein signaling 12 promotes osteoclastogenesis in bone remodeling and pathological bone loss.Hyperglycemia induced and intrinsic alterations in type 2 diabetes-derived osteoclast functionThe Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis.γ-Glutamyltranspeptidase is an endogenous activator of Toll-like receptor 4-mediated osteoclastogenesis.Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursorsProtective effects of recombinant human cytoglobin against chronic alcohol-induced liver disease in vivo and in vitro.TLR4 signalling in osteoarthritis--finding targets for candidate DMOADs.PKR regulates LPS-induced osteoclast formation and bone destruction in vitro and in vivo.The osteoimmunology of alveolar bone loss.Involvement of redox balance in in vitro osteoclast formation of RAW 264.7 macrophage cells in response to LPS.Effects of Porphyromonas gingivalis surface-associated material on osteoclast formation.Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue.Exogenous regucalcin stimulates osteoclastogenesis and suppresses osteoblastogenesis through NF-κB activation.Zinc stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation.Effect of Porphyromonas gingivalis lipopolysaccharide (Pg-LPS) on the expression of EphA2 in osteoblasts and osteoclasts.NAMPT enzyme activity regulates catabolic gene expression in gingival fibroblasts during periodontitis.Plasmin is essential in preventing periodontitis in mice.Cot kinase promotes Ca2+ oscillation/calcineurin-independent osteoclastogenesis by stabilizing NFATc1 protein.The intact strontium ranelate complex stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation.Cyclophosphamide causes osteoporosis in C57BL/6 male mice: suppressive effects of cyclophosphamide on osteoblastogenesis and osteoclastogenesis.Dietary Fats and Osteoarthritis: Insights, Evidences, and New Horizons.Activation of the liver X receptor-β potently inhibits osteoclastogenesis from lipopolysaccharide-exposed bone marrow-derived macrophages.Toll-like receptor 2 activation primes and upregulates osteoclastogenesis via lox-1.
P2860
Q26863571-100019B1-21B9-4273-9B8E-05972ABB1F96Q27315989-8196915B-E0D2-44E0-B77F-76D4E4869E21Q28385635-420BCA43-758E-47EE-A260-33C0D8947F29Q33916514-662DEAB3-5468-4A81-8A06-AE58573FF362Q34313876-47A34D58-3CF6-4C98-B027-E8741D6CA524Q34774474-7130DADA-C7B8-4524-A24E-C1C69CC80AA7Q35085107-4688850D-4151-4B20-B081-479D823E796CQ35386678-FE652FDD-7276-4508-B37A-3FD39F77576BQ35664993-841816F8-8393-4905-B7C0-C22109B88E2FQ35666187-1651038A-74D5-4570-8B17-BB49E39876B4Q35890262-DFB2A286-9AC5-4FBC-AAEA-9FCAF30A0384Q35987370-C5EBB9E0-BC05-4097-B740-25E2FE35C14BQ36188882-9D933AAA-B157-452E-8365-F4BD7255FAC8Q36257329-B183EDDF-2185-423E-B19C-52837F3FB16CQ36315765-9878A008-5D0F-4611-B2C6-3ED1C801689CQ36356941-C79669F8-BA9A-4F1D-9689-9D8C539B6E12Q36444288-9A71CB09-6E60-443A-A2DD-640F977A819FQ36751534-7C12BBBD-D302-44CD-A1A1-AA87C7A0A5A5Q37238209-A9992B9E-AA89-46D9-AEBA-96D661830006Q37287589-25BDC272-81FA-4D51-8A00-9CF95E0D859FQ37360437-AFC345F7-FDA8-4870-B9A6-DC29A30325E6Q37438518-3732FCC5-1A8C-47B7-B7EA-5EB22551E5D8Q37609527-DEA0ABFA-2A5D-42D2-A348-CED08D4D43D6Q38289811-ED68F22F-72DC-4260-AE5D-E8173FE8B92AQ38741964-B85A099B-DF1C-47C2-8171-0AD54991180AQ38763612-93E3BF7D-6AF6-43CB-BFAF-6923775DBF89Q39018581-E027E390-DABD-4030-AA1B-100CBAC31B4AQ39344809-B7A7FF90-C4C7-461F-90F4-663612825B4DQ39475508-A1F88709-E436-4364-9587-B7069747A0E2Q39490131-7D46B0FE-1C12-42AA-9F54-899D2467D53FQ39550193-6000F201-00F9-437F-93F0-2BBE4A859D97Q40332591-5021D7CE-DF98-4A09-9F47-452515638F91Q41583248-AC09F0AA-BDEE-4C3A-8B98-5BAD2123BF4AQ42124151-74E35EA2-03F5-4FB7-A985-C942FEEEA8C6Q42270419-657CFC69-8618-407B-A89D-5EB1215FF1E5Q45422823-182A95D8-CE94-46F8-AF2A-30290A2705D4Q47104810-84651CBB-55E8-4600-8557-36B7C4321147Q50137945-AE13AA45-A52F-41D0-B6F1-D2E44C209607Q54286064-401CF398-0756-4F6F-9FC1-10632E6B5FEDQ54977323-95A97B2F-8B9C-479B-8880-D0B9C5088A48
P2860
Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis
@en
Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis.
@nl
type
label
Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis
@en
Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis.
@nl
prefLabel
Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis
@en
Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis.
@nl
P2093
P2860
P356
P1476
Molecular mechanism of the bifunctional role of lipopolysaccharide in osteoclastogenesis
@en
P2093
Jianzhong Liu
Nasser Said-Al-Naief
Ping Zhang
Shunqing Wang
Suzanne M Michalek
P2860
P304
12512-12523
P356
10.1074/JBC.M809789200
P407
P577
2009-03-03T00:00:00Z